Global Biologic Medications for Psoriasis Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Biologic Medications for Psoriasis market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Biologic medications for psoriasis are advanced therapeutic agents derived from living organisms that specifically target and modulate the immune system's activity involved in the disease.These medications are typically used for moderate to severe psoriasis and are administered through injections or infusions.
This report is a detailed and comprehensive analysis for global Biologic Medications for Psoriasis market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Biologic medications for psoriasis are advanced therapeutic agents derived from living organisms that specifically target and modulate the immune system's activity involved in the disease.These medications are typically used for moderate to severe psoriasis and are administered through injections or infusions.
This report is a detailed and comprehensive analysis for global Biologic Medications for Psoriasis market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
- Global Biologic Medications for Psoriasis market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
- Global Biologic Medications for Psoriasis market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
- Global Biologic Medications for Psoriasis market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
- Global Biologic Medications for Psoriasis market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Biologic Medications for Psoriasis
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Biologic Medications for Psoriasis market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.Market segment by Type
- TNF-α Inhibitors
- Interleukin Inhibitors
- Tyrosine Kinase Inhibitors
- Phosphodiesterase Inhibitors
- Other
Market segment by Application
- Hospital and Clinic
- Retail Pharmacies
- Other
Major players covered
- Bristol-Myers Squibb
- Amgen
- Tiefenbacher Pharmaceuticals
- UCB
- Janssen Biotech
- Eli Lilly
- AbbVie Biotechnology
- Dalian Yawei Pharmaceutical
- Novartis
- Ortho Dermatologics
- LEO Pharma
- Kyowa Kirin
- Boehringer Ingelheim Pharmaceuticals
- Pfizer
- Samsung Bioepis
- Qilu Pharmaceutical
- Hanwha Chemical
- China Medical System
Market segment by region, regional analysis covers
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
- Chapter 1, to describe Biologic Medications for Psoriasis product scope, market overview, market estimation caveats and base year.
- Chapter 2, to profile the top manufacturers of Biologic Medications for Psoriasis, with price, sales quantity, revenue, and global market share of Biologic Medications for Psoriasis from 2021 to 2026.
- Chapter 3, the Biologic Medications for Psoriasis competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
- Chapter 4, the Biologic Medications for Psoriasis breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
- Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
- Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Biologic Medications for Psoriasis market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
- Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
- Chapter 13, the key raw materials and key suppliers, and industry chain of Biologic Medications for Psoriasis.
- Chapter 14 and 15, to describe Biologic Medications for Psoriasis sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Biologic Medications for Psoriasis Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 TNF-α Inhibitors
1.3.3 Interleukin Inhibitors
1.3.4 Tyrosine Kinase Inhibitors
1.3.5 Phosphodiesterase Inhibitors
1.3.6 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Biologic Medications for Psoriasis Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.4.2 Hospital and Clinic
1.4.3 Retail Pharmacies
1.4.4 Other
1.5 Global Biologic Medications for Psoriasis Market Size & Forecast
1.5.1 Global Biologic Medications for Psoriasis Consumption Value (2021 & 2025 & 2032)
1.5.2 Global Biologic Medications for Psoriasis Sales Quantity (2021-2032)
1.5.3 Global Biologic Medications for Psoriasis Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Bristol-Myers Squibb
2.1.1 Bristol-Myers Squibb Details
2.1.2 Bristol-Myers Squibb Major Business
2.1.3 Bristol-Myers Squibb Biologic Medications for Psoriasis Product and Services
2.1.4 Bristol-Myers Squibb Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Bristol-Myers Squibb Recent Developments/Updates
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Biologic Medications for Psoriasis Product and Services
2.2.4 Amgen Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Amgen Recent Developments/Updates
2.3 Tiefenbacher Pharmaceuticals
2.3.1 Tiefenbacher Pharmaceuticals Details
2.3.2 Tiefenbacher Pharmaceuticals Major Business
2.3.3 Tiefenbacher Pharmaceuticals Biologic Medications for Psoriasis Product and Services
2.3.4 Tiefenbacher Pharmaceuticals Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Tiefenbacher Pharmaceuticals Recent Developments/Updates
2.4 UCB
2.4.1 UCB Details
2.4.2 UCB Major Business
2.4.3 UCB Biologic Medications for Psoriasis Product and Services
2.4.4 UCB Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 UCB Recent Developments/Updates
2.5 Janssen Biotech
2.5.1 Janssen Biotech Details
2.5.2 Janssen Biotech Major Business
2.5.3 Janssen Biotech Biologic Medications for Psoriasis Product and Services
2.5.4 Janssen Biotech Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Janssen Biotech Recent Developments/Updates
2.6 Eli Lilly
2.6.1 Eli Lilly Details
2.6.2 Eli Lilly Major Business
2.6.3 Eli Lilly Biologic Medications for Psoriasis Product and Services
2.6.4 Eli Lilly Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Eli Lilly Recent Developments/Updates
2.7 AbbVie Biotechnology
2.7.1 AbbVie Biotechnology Details
2.7.2 AbbVie Biotechnology Major Business
2.7.3 AbbVie Biotechnology Biologic Medications for Psoriasis Product and Services
2.7.4 AbbVie Biotechnology Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 AbbVie Biotechnology Recent Developments/Updates
2.8 Dalian Yawei Pharmaceutical
2.8.1 Dalian Yawei Pharmaceutical Details
2.8.2 Dalian Yawei Pharmaceutical Major Business
2.8.3 Dalian Yawei Pharmaceutical Biologic Medications for Psoriasis Product and Services
2.8.4 Dalian Yawei Pharmaceutical Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Dalian Yawei Pharmaceutical Recent Developments/Updates
2.9 Novartis
2.9.1 Novartis Details
2.9.2 Novartis Major Business
2.9.3 Novartis Biologic Medications for Psoriasis Product and Services
2.9.4 Novartis Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Novartis Recent Developments/Updates
2.10 Ortho Dermatologics
2.10.1 Ortho Dermatologics Details
2.10.2 Ortho Dermatologics Major Business
2.10.3 Ortho Dermatologics Biologic Medications for Psoriasis Product and Services
2.10.4 Ortho Dermatologics Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Ortho Dermatologics Recent Developments/Updates
2.11 LEO Pharma
2.11.1 LEO Pharma Details
2.11.2 LEO Pharma Major Business
2.11.3 LEO Pharma Biologic Medications for Psoriasis Product and Services
2.11.4 LEO Pharma Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 LEO Pharma Recent Developments/Updates
2.12 Kyowa Kirin
2.12.1 Kyowa Kirin Details
2.12.2 Kyowa Kirin Major Business
2.12.3 Kyowa Kirin Biologic Medications for Psoriasis Product and Services
2.12.4 Kyowa Kirin Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Kyowa Kirin Recent Developments/Updates
2.13 Boehringer Ingelheim Pharmaceuticals
2.13.1 Boehringer Ingelheim Pharmaceuticals Details
2.13.2 Boehringer Ingelheim Pharmaceuticals Major Business
2.13.3 Boehringer Ingelheim Pharmaceuticals Biologic Medications for Psoriasis Product and Services
2.13.4 Boehringer Ingelheim Pharmaceuticals Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Boehringer Ingelheim Pharmaceuticals Recent Developments/Updates
2.14 Pfizer
2.14.1 Pfizer Details
2.14.2 Pfizer Major Business
2.14.3 Pfizer Biologic Medications for Psoriasis Product and Services
2.14.4 Pfizer Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Pfizer Recent Developments/Updates
2.15 Samsung Bioepis
2.15.1 Samsung Bioepis Details
2.15.2 Samsung Bioepis Major Business
2.15.3 Samsung Bioepis Biologic Medications for Psoriasis Product and Services
2.15.4 Samsung Bioepis Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Samsung Bioepis Recent Developments/Updates
2.16 Qilu Pharmaceutical
2.16.1 Qilu Pharmaceutical Details
2.16.2 Qilu Pharmaceutical Major Business
2.16.3 Qilu Pharmaceutical Biologic Medications for Psoriasis Product and Services
2.16.4 Qilu Pharmaceutical Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Qilu Pharmaceutical Recent Developments/Updates
2.17 Hanwha Chemical
2.17.1 Hanwha Chemical Details
2.17.2 Hanwha Chemical Major Business
2.17.3 Hanwha Chemical Biologic Medications for Psoriasis Product and Services
2.17.4 Hanwha Chemical Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Hanwha Chemical Recent Developments/Updates
2.18 China Medical System
2.18.1 China Medical System Details
2.18.2 China Medical System Major Business
2.18.3 China Medical System Biologic Medications for Psoriasis Product and Services
2.18.4 China Medical System Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 China Medical System Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: BIOLOGIC MEDICATIONS FOR PSORIASIS BY MANUFACTURER
3.1 Global Biologic Medications for Psoriasis Sales Quantity by Manufacturer (2021-2026)
3.2 Global Biologic Medications for Psoriasis Revenue by Manufacturer (2021-2026)
3.3 Global Biologic Medications for Psoriasis Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Biologic Medications for Psoriasis by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Biologic Medications for Psoriasis Manufacturer Market Share in 2025
3.4.3 Top 6 Biologic Medications for Psoriasis Manufacturer Market Share in 2025
3.5 Biologic Medications for Psoriasis Market: Overall Company Footprint Analysis
3.5.1 Biologic Medications for Psoriasis Market: Region Footprint
3.5.2 Biologic Medications for Psoriasis Market: Company Product Type Footprint
3.5.3 Biologic Medications for Psoriasis Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Biologic Medications for Psoriasis Market Size by Region
4.1.1 Global Biologic Medications for Psoriasis Sales Quantity by Region (2021-2032)
4.1.2 Global Biologic Medications for Psoriasis Consumption Value by Region (2021-2032)
4.1.3 Global Biologic Medications for Psoriasis Average Price by Region (2021-2032)
4.2 North America Biologic Medications for Psoriasis Consumption Value (2021-2032)
4.3 Europe Biologic Medications for Psoriasis Consumption Value (2021-2032)
4.4 Asia-Pacific Biologic Medications for Psoriasis Consumption Value (2021-2032)
4.5 South America Biologic Medications for Psoriasis Consumption Value (2021-2032)
4.6 Middle East & Africa Biologic Medications for Psoriasis Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Biologic Medications for Psoriasis Sales Quantity by Type (2021-2032)
5.2 Global Biologic Medications for Psoriasis Consumption Value by Type (2021-2032)
5.3 Global Biologic Medications for Psoriasis Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Biologic Medications for Psoriasis Sales Quantity by Application (2021-2032)
6.2 Global Biologic Medications for Psoriasis Consumption Value by Application (2021-2032)
6.3 Global Biologic Medications for Psoriasis Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Biologic Medications for Psoriasis Sales Quantity by Type (2021-2032)
7.2 North America Biologic Medications for Psoriasis Sales Quantity by Application (2021-2032)
7.3 North America Biologic Medications for Psoriasis Market Size by Country
7.3.1 North America Biologic Medications for Psoriasis Sales Quantity by Country (2021-2032)
7.3.2 North America Biologic Medications for Psoriasis Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Biologic Medications for Psoriasis Sales Quantity by Type (2021-2032)
8.2 Europe Biologic Medications for Psoriasis Sales Quantity by Application (2021-2032)
8.3 Europe Biologic Medications for Psoriasis Market Size by Country
8.3.1 Europe Biologic Medications for Psoriasis Sales Quantity by Country (2021-2032)
8.3.2 Europe Biologic Medications for Psoriasis Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Biologic Medications for Psoriasis Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Biologic Medications for Psoriasis Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Biologic Medications for Psoriasis Market Size by Region
9.3.1 Asia-Pacific Biologic Medications for Psoriasis Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Biologic Medications for Psoriasis Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Biologic Medications for Psoriasis Sales Quantity by Type (2021-2032)
10.2 South America Biologic Medications for Psoriasis Sales Quantity by Application (2021-2032)
10.3 South America Biologic Medications for Psoriasis Market Size by Country
10.3.1 South America Biologic Medications for Psoriasis Sales Quantity by Country (2021-2032)
10.3.2 South America Biologic Medications for Psoriasis Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Biologic Medications for Psoriasis Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Biologic Medications for Psoriasis Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Biologic Medications for Psoriasis Market Size by Country
11.3.1 Middle East & Africa Biologic Medications for Psoriasis Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Biologic Medications for Psoriasis Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Biologic Medications for Psoriasis Market Drivers
12.2 Biologic Medications for Psoriasis Market Restraints
12.3 Biologic Medications for Psoriasis Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Biologic Medications for Psoriasis and Key Manufacturers
13.2 Manufacturing Costs Percentage of Biologic Medications for Psoriasis
13.3 Biologic Medications for Psoriasis Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Biologic Medications for Psoriasis Typical Distributors
14.3 Biologic Medications for Psoriasis Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Biologic Medications for Psoriasis Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 TNF-α Inhibitors
1.3.3 Interleukin Inhibitors
1.3.4 Tyrosine Kinase Inhibitors
1.3.5 Phosphodiesterase Inhibitors
1.3.6 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Biologic Medications for Psoriasis Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.4.2 Hospital and Clinic
1.4.3 Retail Pharmacies
1.4.4 Other
1.5 Global Biologic Medications for Psoriasis Market Size & Forecast
1.5.1 Global Biologic Medications for Psoriasis Consumption Value (2021 & 2025 & 2032)
1.5.2 Global Biologic Medications for Psoriasis Sales Quantity (2021-2032)
1.5.3 Global Biologic Medications for Psoriasis Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Bristol-Myers Squibb
2.1.1 Bristol-Myers Squibb Details
2.1.2 Bristol-Myers Squibb Major Business
2.1.3 Bristol-Myers Squibb Biologic Medications for Psoriasis Product and Services
2.1.4 Bristol-Myers Squibb Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Bristol-Myers Squibb Recent Developments/Updates
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Biologic Medications for Psoriasis Product and Services
2.2.4 Amgen Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Amgen Recent Developments/Updates
2.3 Tiefenbacher Pharmaceuticals
2.3.1 Tiefenbacher Pharmaceuticals Details
2.3.2 Tiefenbacher Pharmaceuticals Major Business
2.3.3 Tiefenbacher Pharmaceuticals Biologic Medications for Psoriasis Product and Services
2.3.4 Tiefenbacher Pharmaceuticals Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Tiefenbacher Pharmaceuticals Recent Developments/Updates
2.4 UCB
2.4.1 UCB Details
2.4.2 UCB Major Business
2.4.3 UCB Biologic Medications for Psoriasis Product and Services
2.4.4 UCB Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 UCB Recent Developments/Updates
2.5 Janssen Biotech
2.5.1 Janssen Biotech Details
2.5.2 Janssen Biotech Major Business
2.5.3 Janssen Biotech Biologic Medications for Psoriasis Product and Services
2.5.4 Janssen Biotech Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Janssen Biotech Recent Developments/Updates
2.6 Eli Lilly
2.6.1 Eli Lilly Details
2.6.2 Eli Lilly Major Business
2.6.3 Eli Lilly Biologic Medications for Psoriasis Product and Services
2.6.4 Eli Lilly Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Eli Lilly Recent Developments/Updates
2.7 AbbVie Biotechnology
2.7.1 AbbVie Biotechnology Details
2.7.2 AbbVie Biotechnology Major Business
2.7.3 AbbVie Biotechnology Biologic Medications for Psoriasis Product and Services
2.7.4 AbbVie Biotechnology Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 AbbVie Biotechnology Recent Developments/Updates
2.8 Dalian Yawei Pharmaceutical
2.8.1 Dalian Yawei Pharmaceutical Details
2.8.2 Dalian Yawei Pharmaceutical Major Business
2.8.3 Dalian Yawei Pharmaceutical Biologic Medications for Psoriasis Product and Services
2.8.4 Dalian Yawei Pharmaceutical Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Dalian Yawei Pharmaceutical Recent Developments/Updates
2.9 Novartis
2.9.1 Novartis Details
2.9.2 Novartis Major Business
2.9.3 Novartis Biologic Medications for Psoriasis Product and Services
2.9.4 Novartis Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Novartis Recent Developments/Updates
2.10 Ortho Dermatologics
2.10.1 Ortho Dermatologics Details
2.10.2 Ortho Dermatologics Major Business
2.10.3 Ortho Dermatologics Biologic Medications for Psoriasis Product and Services
2.10.4 Ortho Dermatologics Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Ortho Dermatologics Recent Developments/Updates
2.11 LEO Pharma
2.11.1 LEO Pharma Details
2.11.2 LEO Pharma Major Business
2.11.3 LEO Pharma Biologic Medications for Psoriasis Product and Services
2.11.4 LEO Pharma Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 LEO Pharma Recent Developments/Updates
2.12 Kyowa Kirin
2.12.1 Kyowa Kirin Details
2.12.2 Kyowa Kirin Major Business
2.12.3 Kyowa Kirin Biologic Medications for Psoriasis Product and Services
2.12.4 Kyowa Kirin Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Kyowa Kirin Recent Developments/Updates
2.13 Boehringer Ingelheim Pharmaceuticals
2.13.1 Boehringer Ingelheim Pharmaceuticals Details
2.13.2 Boehringer Ingelheim Pharmaceuticals Major Business
2.13.3 Boehringer Ingelheim Pharmaceuticals Biologic Medications for Psoriasis Product and Services
2.13.4 Boehringer Ingelheim Pharmaceuticals Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Boehringer Ingelheim Pharmaceuticals Recent Developments/Updates
2.14 Pfizer
2.14.1 Pfizer Details
2.14.2 Pfizer Major Business
2.14.3 Pfizer Biologic Medications for Psoriasis Product and Services
2.14.4 Pfizer Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Pfizer Recent Developments/Updates
2.15 Samsung Bioepis
2.15.1 Samsung Bioepis Details
2.15.2 Samsung Bioepis Major Business
2.15.3 Samsung Bioepis Biologic Medications for Psoriasis Product and Services
2.15.4 Samsung Bioepis Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Samsung Bioepis Recent Developments/Updates
2.16 Qilu Pharmaceutical
2.16.1 Qilu Pharmaceutical Details
2.16.2 Qilu Pharmaceutical Major Business
2.16.3 Qilu Pharmaceutical Biologic Medications for Psoriasis Product and Services
2.16.4 Qilu Pharmaceutical Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Qilu Pharmaceutical Recent Developments/Updates
2.17 Hanwha Chemical
2.17.1 Hanwha Chemical Details
2.17.2 Hanwha Chemical Major Business
2.17.3 Hanwha Chemical Biologic Medications for Psoriasis Product and Services
2.17.4 Hanwha Chemical Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Hanwha Chemical Recent Developments/Updates
2.18 China Medical System
2.18.1 China Medical System Details
2.18.2 China Medical System Major Business
2.18.3 China Medical System Biologic Medications for Psoriasis Product and Services
2.18.4 China Medical System Biologic Medications for Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 China Medical System Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: BIOLOGIC MEDICATIONS FOR PSORIASIS BY MANUFACTURER
3.1 Global Biologic Medications for Psoriasis Sales Quantity by Manufacturer (2021-2026)
3.2 Global Biologic Medications for Psoriasis Revenue by Manufacturer (2021-2026)
3.3 Global Biologic Medications for Psoriasis Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Biologic Medications for Psoriasis by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Biologic Medications for Psoriasis Manufacturer Market Share in 2025
3.4.3 Top 6 Biologic Medications for Psoriasis Manufacturer Market Share in 2025
3.5 Biologic Medications for Psoriasis Market: Overall Company Footprint Analysis
3.5.1 Biologic Medications for Psoriasis Market: Region Footprint
3.5.2 Biologic Medications for Psoriasis Market: Company Product Type Footprint
3.5.3 Biologic Medications for Psoriasis Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Biologic Medications for Psoriasis Market Size by Region
4.1.1 Global Biologic Medications for Psoriasis Sales Quantity by Region (2021-2032)
4.1.2 Global Biologic Medications for Psoriasis Consumption Value by Region (2021-2032)
4.1.3 Global Biologic Medications for Psoriasis Average Price by Region (2021-2032)
4.2 North America Biologic Medications for Psoriasis Consumption Value (2021-2032)
4.3 Europe Biologic Medications for Psoriasis Consumption Value (2021-2032)
4.4 Asia-Pacific Biologic Medications for Psoriasis Consumption Value (2021-2032)
4.5 South America Biologic Medications for Psoriasis Consumption Value (2021-2032)
4.6 Middle East & Africa Biologic Medications for Psoriasis Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Biologic Medications for Psoriasis Sales Quantity by Type (2021-2032)
5.2 Global Biologic Medications for Psoriasis Consumption Value by Type (2021-2032)
5.3 Global Biologic Medications for Psoriasis Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Biologic Medications for Psoriasis Sales Quantity by Application (2021-2032)
6.2 Global Biologic Medications for Psoriasis Consumption Value by Application (2021-2032)
6.3 Global Biologic Medications for Psoriasis Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Biologic Medications for Psoriasis Sales Quantity by Type (2021-2032)
7.2 North America Biologic Medications for Psoriasis Sales Quantity by Application (2021-2032)
7.3 North America Biologic Medications for Psoriasis Market Size by Country
7.3.1 North America Biologic Medications for Psoriasis Sales Quantity by Country (2021-2032)
7.3.2 North America Biologic Medications for Psoriasis Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Biologic Medications for Psoriasis Sales Quantity by Type (2021-2032)
8.2 Europe Biologic Medications for Psoriasis Sales Quantity by Application (2021-2032)
8.3 Europe Biologic Medications for Psoriasis Market Size by Country
8.3.1 Europe Biologic Medications for Psoriasis Sales Quantity by Country (2021-2032)
8.3.2 Europe Biologic Medications for Psoriasis Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Biologic Medications for Psoriasis Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Biologic Medications for Psoriasis Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Biologic Medications for Psoriasis Market Size by Region
9.3.1 Asia-Pacific Biologic Medications for Psoriasis Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Biologic Medications for Psoriasis Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Biologic Medications for Psoriasis Sales Quantity by Type (2021-2032)
10.2 South America Biologic Medications for Psoriasis Sales Quantity by Application (2021-2032)
10.3 South America Biologic Medications for Psoriasis Market Size by Country
10.3.1 South America Biologic Medications for Psoriasis Sales Quantity by Country (2021-2032)
10.3.2 South America Biologic Medications for Psoriasis Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Biologic Medications for Psoriasis Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Biologic Medications for Psoriasis Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Biologic Medications for Psoriasis Market Size by Country
11.3.1 Middle East & Africa Biologic Medications for Psoriasis Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Biologic Medications for Psoriasis Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Biologic Medications for Psoriasis Market Drivers
12.2 Biologic Medications for Psoriasis Market Restraints
12.3 Biologic Medications for Psoriasis Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Biologic Medications for Psoriasis and Key Manufacturers
13.2 Manufacturing Costs Percentage of Biologic Medications for Psoriasis
13.3 Biologic Medications for Psoriasis Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Biologic Medications for Psoriasis Typical Distributors
14.3 Biologic Medications for Psoriasis Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Biologic Medications for Psoriasis Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Biologic Medications for Psoriasis Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 4. Bristol-Myers Squibb Major Business
Table 5. Bristol-Myers Squibb Biologic Medications for Psoriasis Product and Services
Table 6. Bristol-Myers Squibb Biologic Medications for Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 7. Bristol-Myers Squibb Recent Developments/Updates
Table 8. Amgen Basic Information, Manufacturing Base and Competitors
Table 9. Amgen Major Business
Table 10. Amgen Biologic Medications for Psoriasis Product and Services
Table 11. Amgen Biologic Medications for Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. Amgen Recent Developments/Updates
Table 13. Tiefenbacher Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 14. Tiefenbacher Pharmaceuticals Major Business
Table 15. Tiefenbacher Pharmaceuticals Biologic Medications for Psoriasis Product and Services
Table 16. Tiefenbacher Pharmaceuticals Biologic Medications for Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. Tiefenbacher Pharmaceuticals Recent Developments/Updates
Table 18. UCB Basic Information, Manufacturing Base and Competitors
Table 19. UCB Major Business
Table 20. UCB Biologic Medications for Psoriasis Product and Services
Table 21. UCB Biologic Medications for Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. UCB Recent Developments/Updates
Table 23. Janssen Biotech Basic Information, Manufacturing Base and Competitors
Table 24. Janssen Biotech Major Business
Table 25. Janssen Biotech Biologic Medications for Psoriasis Product and Services
Table 26. Janssen Biotech Biologic Medications for Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 27. Janssen Biotech Recent Developments/Updates
Table 28. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 29. Eli Lilly Major Business
Table 30. Eli Lilly Biologic Medications for Psoriasis Product and Services
Table 31. Eli Lilly Biologic Medications for Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 32. Eli Lilly Recent Developments/Updates
Table 33. AbbVie Biotechnology Basic Information, Manufacturing Base and Competitors
Table 34. AbbVie Biotechnology Major Business
Table 35. AbbVie Biotechnology Biologic Medications for Psoriasis Product and Services
Table 36. AbbVie Biotechnology Biologic Medications for Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 37. AbbVie Biotechnology Recent Developments/Updates
Table 38. Dalian Yawei Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 39. Dalian Yawei Pharmaceutical Major Business
Table 40. Dalian Yawei Pharmaceutical Biologic Medications for Psoriasis Product and Services
Table 41. Dalian Yawei Pharmaceutical Biologic Medications for Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 42. Dalian Yawei Pharmaceutical Recent Developments/Updates
Table 43. Novartis Basic Information, Manufacturing Base and Competitors
Table 44. Novartis Major Business
Table 45. Novartis Biologic Medications for Psoriasis Product and Services
Table 46. Novartis Biologic Medications for Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 47. Novartis Recent Developments/Updates
Table 48. Ortho Dermatologics Basic Information, Manufacturing Base and Competitors
Table 49. Ortho Dermatologics Major Business
Table 50. Ortho Dermatologics Biologic Medications for Psoriasis Product and Services
Table 51. Ortho Dermatologics Biologic Medications for Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 52. Ortho Dermatologics Recent Developments/Updates
Table 53. LEO Pharma Basic Information, Manufacturing Base and Competitors
Table 54. LEO Pharma Major Business
Table 55. LEO Pharma Biologic Medications for Psoriasis Product and Services
Table 56. LEO Pharma Biologic Medications for Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 57. LEO Pharma Recent Developments/Updates
Table 58. Kyowa Kirin Basic Information, Manufacturing Base and Competitors
Table 59. Kyowa Kirin Major Business
Table 60. Kyowa Kirin Biologic Medications for Psoriasis Product and Services
Table 61. Kyowa Kirin Biologic Medications for Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 62. Kyowa Kirin Recent Developments/Updates
Table 63. Boehringer Ingelheim Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 64. Boehringer Ingelheim Pharmaceuticals Major Business
Table 65. Boehringer Ingelheim Pharmaceuticals Biologic Medications for Psoriasis Product and Services
Table 66. Boehringer Ingelheim Pharmaceuticals Biologic Medications for Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 67. Boehringer Ingelheim Pharmaceuticals Recent Developments/Updates
Table 68. Pfizer Basic Information, Manufacturing Base and Competitors
Table 69. Pfizer Major Business
Table 70. Pfizer Biologic Medications for Psoriasis Product and Services
Table 71. Pfizer Biologic Medications for Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 72. Pfizer Recent Developments/Updates
Table 73. Samsung Bioepis Basic Information, Manufacturing Base and Competitors
Table 74. Samsung Bioepis Major Business
Table 75. Samsung Bioepis Biologic Medications for Psoriasis Product and Services
Table 76. Samsung Bioepis Biologic Medications for Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 77. Samsung Bioepis Recent Developments/Updates
Table 78. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 79. Qilu Pharmaceutical Major Business
Table 80. Qilu Pharmaceutical Biologic Medications for Psoriasis Product and Services
Table 81. Qilu Pharmaceutical Biologic Medications for Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 82. Qilu Pharmaceutical Recent Developments/Updates
Table 83. Hanwha Chemical Basic Information, Manufacturing Base and Competitors
Table 84. Hanwha Chemical Major Business
Table 85. Hanwha Chemical Biologic Medications for Psoriasis Product and Services
Table 86. Hanwha Chemical Biologic Medications for Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 87. Hanwha Chemical Recent Developments/Updates
Table 88. China Medical System Basic Information, Manufacturing Base and Competitors
Table 89. China Medical System Major Business
Table 90. China Medical System Biologic Medications for Psoriasis Product and Services
Table 91. China Medical System Biologic Medications for Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 92. China Medical System Recent Developments/Updates
Table 93. Global Biologic Medications for Psoriasis Sales Quantity by Manufacturer (2021-2026) & (K Units)
Table 94. Global Biologic Medications for Psoriasis Revenue by Manufacturer (2021-2026) & (USD Million)
Table 95. Global Biologic Medications for Psoriasis Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 96. Market Position of Manufacturers in Biologic Medications for Psoriasis, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 97. Head Office and Biologic Medications for Psoriasis Production Site of Key Manufacturer
Table 98. Biologic Medications for Psoriasis Market: Company Product Type Footprint
Table 99. Biologic Medications for Psoriasis Market: Company Product Application Footprint
Table 100. Biologic Medications for Psoriasis New Market Entrants and Barriers to Market Entry
Table 101. Biologic Medications for Psoriasis Mergers, Acquisition, Agreements, and Collaborations
Table 102. Global Biologic Medications for Psoriasis Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 103. Global Biologic Medications for Psoriasis Sales Quantity by Region (2021-2026) & (K Units)
Table 104. Global Biologic Medications for Psoriasis Sales Quantity by Region (2027-2032) & (K Units)
Table 105. Global Biologic Medications for Psoriasis Consumption Value by Region (2021-2026) & (USD Million)
Table 106. Global Biologic Medications for Psoriasis Consumption Value by Region (2027-2032) & (USD Million)
Table 107. Global Biologic Medications for Psoriasis Average Price by Region (2021-2026) & (US$/Unit)
Table 108. Global Biologic Medications for Psoriasis Average Price by Region (2027-2032) & (US$/Unit)
Table 109. Global Biologic Medications for Psoriasis Sales Quantity by Type (2021-2026) & (K Units)
Table 110. Global Biologic Medications for Psoriasis Sales Quantity by Type (2027-2032) & (K Units)
Table 111. Global Biologic Medications for Psoriasis Consumption Value by Type (2021-2026) & (USD Million)
Table 112. Global Biologic Medications for Psoriasis Consumption Value by Type (2027-2032) & (USD Million)
Table 113. Global Biologic Medications for Psoriasis Average Price by Type (2021-2026) & (US$/Unit)
Table 114. Global Biologic Medications for Psoriasis Average Price by Type (2027-2032) & (US$/Unit)
Table 115. Global Biologic Medications for Psoriasis Sales Quantity by Application (2021-2026) & (K Units)
Table 116. Global Biologic Medications for Psoriasis Sales Quantity by Application (2027-2032) & (K Units)
Table 117. Global Biologic Medications for Psoriasis Consumption Value by Application (2021-2026) & (USD Million)
Table 118. Global Biologic Medications for Psoriasis Consumption Value by Application (2027-2032) & (USD Million)
Table 119. Global Biologic Medications for Psoriasis Average Price by Application (2021-2026) & (US$/Unit)
Table 120. Global Biologic Medications for Psoriasis Average Price by Application (2027-2032) & (US$/Unit)
Table 121. North America Biologic Medications for Psoriasis Sales Quantity by Type (2021-2026) & (K Units)
Table 122. North America Biologic Medications for Psoriasis Sales Quantity by Type (2027-2032) & (K Units)
Table 123. North America Biologic Medications for Psoriasis Sales Quantity by Application (2021-2026) & (K Units)
Table 124. North America Biologic Medications for Psoriasis Sales Quantity by Application (2027-2032) & (K Units)
Table 125. North America Biologic Medications for Psoriasis Sales Quantity by Country (2021-2026) & (K Units)
Table 126. North America Biologic Medications for Psoriasis Sales Quantity by Country (2027-2032) & (K Units)
Table 127. North America Biologic Medications for Psoriasis Consumption Value by Country (2021-2026) & (USD Million)
Table 128. North America Biologic Medications for Psoriasis Consumption Value by Country (2027-2032) & (USD Million)
Table 129. Europe Biologic Medications for Psoriasis Sales Quantity by Type (2021-2026) & (K Units)
Table 130. Europe Biologic Medications for Psoriasis Sales Quantity by Type (2027-2032) & (K Units)
Table 131. Europe Biologic Medications for Psoriasis Sales Quantity by Application (2021-2026) & (K Units)
Table 132. Europe Biologic Medications for Psoriasis Sales Quantity by Application (2027-2032) & (K Units)
Table 133. Europe Biologic Medications for Psoriasis Sales Quantity by Country (2021-2026) & (K Units)
Table 134. Europe Biologic Medications for Psoriasis Sales Quantity by Country (2027-2032) & (K Units)
Table 135. Europe Biologic Medications for Psoriasis Consumption Value by Country (2021-2026) & (USD Million)
Table 136. Europe Biologic Medications for Psoriasis Consumption Value by Country (2027-2032) & (USD Million)
Table 137. Asia-Pacific Biologic Medications for Psoriasis Sales Quantity by Type (2021-2026) & (K Units)
Table 138. Asia-Pacific Biologic Medications for Psoriasis Sales Quantity by Type (2027-2032) & (K Units)
Table 139. Asia-Pacific Biologic Medications for Psoriasis Sales Quantity by Application (2021-2026) & (K Units)
Table 140. Asia-Pacific Biologic Medications for Psoriasis Sales Quantity by Application (2027-2032) & (K Units)
Table 141. Asia-Pacific Biologic Medications for Psoriasis Sales Quantity by Region (2021-2026) & (K Units)
Table 142. Asia-Pacific Biologic Medications for Psoriasis Sales Quantity by Region (2027-2032) & (K Units)
Table 143. Asia-Pacific Biologic Medications for Psoriasis Consumption Value by Region (2021-2026) & (USD Million)
Table 144. Asia-Pacific Biologic Medications for Psoriasis Consumption Value by Region (2027-2032) & (USD Million)
Table 145. South America Biologic Medications for Psoriasis Sales Quantity by Type (2021-2026) & (K Units)
Table 146. South America Biologic Medications for Psoriasis Sales Quantity by Type (2027-2032) & (K Units)
Table 147. South America Biologic Medications for Psoriasis Sales Quantity by Application (2021-2026) & (K Units)
Table 148. South America Biologic Medications for Psoriasis Sales Quantity by Application (2027-2032) & (K Units)
Table 149. South America Biologic Medications for Psoriasis Sales Quantity by Country (2021-2026) & (K Units)
Table 150. South America Biologic Medications for Psoriasis Sales Quantity by Country (2027-2032) & (K Units)
Table 151. South America Biologic Medications for Psoriasis Consumption Value by Country (2021-2026) & (USD Million)
Table 152. South America Biologic Medications for Psoriasis Consumption Value by Country (2027-2032) & (USD Million)
Table 153. Middle East & Africa Biologic Medications for Psoriasis Sales Quantity by Type (2021-2026) & (K Units)
Table 154. Middle East & Africa Biologic Medications for Psoriasis Sales Quantity by Type (2027-2032) & (K Units)
Table 155. Middle East & Africa Biologic Medications for Psoriasis Sales Quantity by Application (2021-2026) & (K Units)
Table 156. Middle East & Africa Biologic Medications for Psoriasis Sales Quantity by Application (2027-2032) & (K Units)
Table 157. Middle East & Africa Biologic Medications for Psoriasis Sales Quantity by Country (2021-2026) & (K Units)
Table 158. Middle East & Africa Biologic Medications for Psoriasis Sales Quantity by Country (2027-2032) & (K Units)
Table 159. Middle East & Africa Biologic Medications for Psoriasis Consumption Value by Country (2021-2026) & (USD Million)
Table 160. Middle East & Africa Biologic Medications for Psoriasis Consumption Value by Country (2027-2032) & (USD Million)
Table 161. Biologic Medications for Psoriasis Raw Material
Table 162. Key Manufacturers of Biologic Medications for Psoriasis Raw Materials
Table 163. Biologic Medications for Psoriasis Typical Distributors
Table 164. Biologic Medications for Psoriasis Typical Customers
Table 1. Global Biologic Medications for Psoriasis Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Biologic Medications for Psoriasis Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 4. Bristol-Myers Squibb Major Business
Table 5. Bristol-Myers Squibb Biologic Medications for Psoriasis Product and Services
Table 6. Bristol-Myers Squibb Biologic Medications for Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 7. Bristol-Myers Squibb Recent Developments/Updates
Table 8. Amgen Basic Information, Manufacturing Base and Competitors
Table 9. Amgen Major Business
Table 10. Amgen Biologic Medications for Psoriasis Product and Services
Table 11. Amgen Biologic Medications for Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. Amgen Recent Developments/Updates
Table 13. Tiefenbacher Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 14. Tiefenbacher Pharmaceuticals Major Business
Table 15. Tiefenbacher Pharmaceuticals Biologic Medications for Psoriasis Product and Services
Table 16. Tiefenbacher Pharmaceuticals Biologic Medications for Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. Tiefenbacher Pharmaceuticals Recent Developments/Updates
Table 18. UCB Basic Information, Manufacturing Base and Competitors
Table 19. UCB Major Business
Table 20. UCB Biologic Medications for Psoriasis Product and Services
Table 21. UCB Biologic Medications for Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. UCB Recent Developments/Updates
Table 23. Janssen Biotech Basic Information, Manufacturing Base and Competitors
Table 24. Janssen Biotech Major Business
Table 25. Janssen Biotech Biologic Medications for Psoriasis Product and Services
Table 26. Janssen Biotech Biologic Medications for Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 27. Janssen Biotech Recent Developments/Updates
Table 28. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 29. Eli Lilly Major Business
Table 30. Eli Lilly Biologic Medications for Psoriasis Product and Services
Table 31. Eli Lilly Biologic Medications for Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 32. Eli Lilly Recent Developments/Updates
Table 33. AbbVie Biotechnology Basic Information, Manufacturing Base and Competitors
Table 34. AbbVie Biotechnology Major Business
Table 35. AbbVie Biotechnology Biologic Medications for Psoriasis Product and Services
Table 36. AbbVie Biotechnology Biologic Medications for Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 37. AbbVie Biotechnology Recent Developments/Updates
Table 38. Dalian Yawei Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 39. Dalian Yawei Pharmaceutical Major Business
Table 40. Dalian Yawei Pharmaceutical Biologic Medications for Psoriasis Product and Services
Table 41. Dalian Yawei Pharmaceutical Biologic Medications for Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 42. Dalian Yawei Pharmaceutical Recent Developments/Updates
Table 43. Novartis Basic Information, Manufacturing Base and Competitors
Table 44. Novartis Major Business
Table 45. Novartis Biologic Medications for Psoriasis Product and Services
Table 46. Novartis Biologic Medications for Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 47. Novartis Recent Developments/Updates
Table 48. Ortho Dermatologics Basic Information, Manufacturing Base and Competitors
Table 49. Ortho Dermatologics Major Business
Table 50. Ortho Dermatologics Biologic Medications for Psoriasis Product and Services
Table 51. Ortho Dermatologics Biologic Medications for Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 52. Ortho Dermatologics Recent Developments/Updates
Table 53. LEO Pharma Basic Information, Manufacturing Base and Competitors
Table 54. LEO Pharma Major Business
Table 55. LEO Pharma Biologic Medications for Psoriasis Product and Services
Table 56. LEO Pharma Biologic Medications for Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 57. LEO Pharma Recent Developments/Updates
Table 58. Kyowa Kirin Basic Information, Manufacturing Base and Competitors
Table 59. Kyowa Kirin Major Business
Table 60. Kyowa Kirin Biologic Medications for Psoriasis Product and Services
Table 61. Kyowa Kirin Biologic Medications for Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 62. Kyowa Kirin Recent Developments/Updates
Table 63. Boehringer Ingelheim Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 64. Boehringer Ingelheim Pharmaceuticals Major Business
Table 65. Boehringer Ingelheim Pharmaceuticals Biologic Medications for Psoriasis Product and Services
Table 66. Boehringer Ingelheim Pharmaceuticals Biologic Medications for Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 67. Boehringer Ingelheim Pharmaceuticals Recent Developments/Updates
Table 68. Pfizer Basic Information, Manufacturing Base and Competitors
Table 69. Pfizer Major Business
Table 70. Pfizer Biologic Medications for Psoriasis Product and Services
Table 71. Pfizer Biologic Medications for Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 72. Pfizer Recent Developments/Updates
Table 73. Samsung Bioepis Basic Information, Manufacturing Base and Competitors
Table 74. Samsung Bioepis Major Business
Table 75. Samsung Bioepis Biologic Medications for Psoriasis Product and Services
Table 76. Samsung Bioepis Biologic Medications for Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 77. Samsung Bioepis Recent Developments/Updates
Table 78. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 79. Qilu Pharmaceutical Major Business
Table 80. Qilu Pharmaceutical Biologic Medications for Psoriasis Product and Services
Table 81. Qilu Pharmaceutical Biologic Medications for Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 82. Qilu Pharmaceutical Recent Developments/Updates
Table 83. Hanwha Chemical Basic Information, Manufacturing Base and Competitors
Table 84. Hanwha Chemical Major Business
Table 85. Hanwha Chemical Biologic Medications for Psoriasis Product and Services
Table 86. Hanwha Chemical Biologic Medications for Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 87. Hanwha Chemical Recent Developments/Updates
Table 88. China Medical System Basic Information, Manufacturing Base and Competitors
Table 89. China Medical System Major Business
Table 90. China Medical System Biologic Medications for Psoriasis Product and Services
Table 91. China Medical System Biologic Medications for Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 92. China Medical System Recent Developments/Updates
Table 93. Global Biologic Medications for Psoriasis Sales Quantity by Manufacturer (2021-2026) & (K Units)
Table 94. Global Biologic Medications for Psoriasis Revenue by Manufacturer (2021-2026) & (USD Million)
Table 95. Global Biologic Medications for Psoriasis Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 96. Market Position of Manufacturers in Biologic Medications for Psoriasis, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 97. Head Office and Biologic Medications for Psoriasis Production Site of Key Manufacturer
Table 98. Biologic Medications for Psoriasis Market: Company Product Type Footprint
Table 99. Biologic Medications for Psoriasis Market: Company Product Application Footprint
Table 100. Biologic Medications for Psoriasis New Market Entrants and Barriers to Market Entry
Table 101. Biologic Medications for Psoriasis Mergers, Acquisition, Agreements, and Collaborations
Table 102. Global Biologic Medications for Psoriasis Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 103. Global Biologic Medications for Psoriasis Sales Quantity by Region (2021-2026) & (K Units)
Table 104. Global Biologic Medications for Psoriasis Sales Quantity by Region (2027-2032) & (K Units)
Table 105. Global Biologic Medications for Psoriasis Consumption Value by Region (2021-2026) & (USD Million)
Table 106. Global Biologic Medications for Psoriasis Consumption Value by Region (2027-2032) & (USD Million)
Table 107. Global Biologic Medications for Psoriasis Average Price by Region (2021-2026) & (US$/Unit)
Table 108. Global Biologic Medications for Psoriasis Average Price by Region (2027-2032) & (US$/Unit)
Table 109. Global Biologic Medications for Psoriasis Sales Quantity by Type (2021-2026) & (K Units)
Table 110. Global Biologic Medications for Psoriasis Sales Quantity by Type (2027-2032) & (K Units)
Table 111. Global Biologic Medications for Psoriasis Consumption Value by Type (2021-2026) & (USD Million)
Table 112. Global Biologic Medications for Psoriasis Consumption Value by Type (2027-2032) & (USD Million)
Table 113. Global Biologic Medications for Psoriasis Average Price by Type (2021-2026) & (US$/Unit)
Table 114. Global Biologic Medications for Psoriasis Average Price by Type (2027-2032) & (US$/Unit)
Table 115. Global Biologic Medications for Psoriasis Sales Quantity by Application (2021-2026) & (K Units)
Table 116. Global Biologic Medications for Psoriasis Sales Quantity by Application (2027-2032) & (K Units)
Table 117. Global Biologic Medications for Psoriasis Consumption Value by Application (2021-2026) & (USD Million)
Table 118. Global Biologic Medications for Psoriasis Consumption Value by Application (2027-2032) & (USD Million)
Table 119. Global Biologic Medications for Psoriasis Average Price by Application (2021-2026) & (US$/Unit)
Table 120. Global Biologic Medications for Psoriasis Average Price by Application (2027-2032) & (US$/Unit)
Table 121. North America Biologic Medications for Psoriasis Sales Quantity by Type (2021-2026) & (K Units)
Table 122. North America Biologic Medications for Psoriasis Sales Quantity by Type (2027-2032) & (K Units)
Table 123. North America Biologic Medications for Psoriasis Sales Quantity by Application (2021-2026) & (K Units)
Table 124. North America Biologic Medications for Psoriasis Sales Quantity by Application (2027-2032) & (K Units)
Table 125. North America Biologic Medications for Psoriasis Sales Quantity by Country (2021-2026) & (K Units)
Table 126. North America Biologic Medications for Psoriasis Sales Quantity by Country (2027-2032) & (K Units)
Table 127. North America Biologic Medications for Psoriasis Consumption Value by Country (2021-2026) & (USD Million)
Table 128. North America Biologic Medications for Psoriasis Consumption Value by Country (2027-2032) & (USD Million)
Table 129. Europe Biologic Medications for Psoriasis Sales Quantity by Type (2021-2026) & (K Units)
Table 130. Europe Biologic Medications for Psoriasis Sales Quantity by Type (2027-2032) & (K Units)
Table 131. Europe Biologic Medications for Psoriasis Sales Quantity by Application (2021-2026) & (K Units)
Table 132. Europe Biologic Medications for Psoriasis Sales Quantity by Application (2027-2032) & (K Units)
Table 133. Europe Biologic Medications for Psoriasis Sales Quantity by Country (2021-2026) & (K Units)
Table 134. Europe Biologic Medications for Psoriasis Sales Quantity by Country (2027-2032) & (K Units)
Table 135. Europe Biologic Medications for Psoriasis Consumption Value by Country (2021-2026) & (USD Million)
Table 136. Europe Biologic Medications for Psoriasis Consumption Value by Country (2027-2032) & (USD Million)
Table 137. Asia-Pacific Biologic Medications for Psoriasis Sales Quantity by Type (2021-2026) & (K Units)
Table 138. Asia-Pacific Biologic Medications for Psoriasis Sales Quantity by Type (2027-2032) & (K Units)
Table 139. Asia-Pacific Biologic Medications for Psoriasis Sales Quantity by Application (2021-2026) & (K Units)
Table 140. Asia-Pacific Biologic Medications for Psoriasis Sales Quantity by Application (2027-2032) & (K Units)
Table 141. Asia-Pacific Biologic Medications for Psoriasis Sales Quantity by Region (2021-2026) & (K Units)
Table 142. Asia-Pacific Biologic Medications for Psoriasis Sales Quantity by Region (2027-2032) & (K Units)
Table 143. Asia-Pacific Biologic Medications for Psoriasis Consumption Value by Region (2021-2026) & (USD Million)
Table 144. Asia-Pacific Biologic Medications for Psoriasis Consumption Value by Region (2027-2032) & (USD Million)
Table 145. South America Biologic Medications for Psoriasis Sales Quantity by Type (2021-2026) & (K Units)
Table 146. South America Biologic Medications for Psoriasis Sales Quantity by Type (2027-2032) & (K Units)
Table 147. South America Biologic Medications for Psoriasis Sales Quantity by Application (2021-2026) & (K Units)
Table 148. South America Biologic Medications for Psoriasis Sales Quantity by Application (2027-2032) & (K Units)
Table 149. South America Biologic Medications for Psoriasis Sales Quantity by Country (2021-2026) & (K Units)
Table 150. South America Biologic Medications for Psoriasis Sales Quantity by Country (2027-2032) & (K Units)
Table 151. South America Biologic Medications for Psoriasis Consumption Value by Country (2021-2026) & (USD Million)
Table 152. South America Biologic Medications for Psoriasis Consumption Value by Country (2027-2032) & (USD Million)
Table 153. Middle East & Africa Biologic Medications for Psoriasis Sales Quantity by Type (2021-2026) & (K Units)
Table 154. Middle East & Africa Biologic Medications for Psoriasis Sales Quantity by Type (2027-2032) & (K Units)
Table 155. Middle East & Africa Biologic Medications for Psoriasis Sales Quantity by Application (2021-2026) & (K Units)
Table 156. Middle East & Africa Biologic Medications for Psoriasis Sales Quantity by Application (2027-2032) & (K Units)
Table 157. Middle East & Africa Biologic Medications for Psoriasis Sales Quantity by Country (2021-2026) & (K Units)
Table 158. Middle East & Africa Biologic Medications for Psoriasis Sales Quantity by Country (2027-2032) & (K Units)
Table 159. Middle East & Africa Biologic Medications for Psoriasis Consumption Value by Country (2021-2026) & (USD Million)
Table 160. Middle East & Africa Biologic Medications for Psoriasis Consumption Value by Country (2027-2032) & (USD Million)
Table 161. Biologic Medications for Psoriasis Raw Material
Table 162. Key Manufacturers of Biologic Medications for Psoriasis Raw Materials
Table 163. Biologic Medications for Psoriasis Typical Distributors
Table 164. Biologic Medications for Psoriasis Typical Customers
LIST OF FIGURES
Figure 1. Biologic Medications for Psoriasis Picture
Figure 2. Global Biologic Medications for Psoriasis Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Biologic Medications for Psoriasis Revenue Market Share by Type in 2025
Figure 4. TNF-α Inhibitors Examples
Figure 5. Interleukin Inhibitors Examples
Figure 6. Tyrosine Kinase Inhibitors Examples
Figure 7. Phosphodiesterase Inhibitors Examples
Figure 8. Other Examples
Figure 9. Global Biologic Medications for Psoriasis Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 10. Global Biologic Medications for Psoriasis Revenue Market Share by Application in 2025
Figure 11. Hospital and Clinic Examples
Figure 12. Retail Pharmacies Examples
Figure 13. Other Examples
Figure 14. Global Biologic Medications for Psoriasis Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 15. Global Biologic Medications for Psoriasis Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 16. Global Biologic Medications for Psoriasis Sales Quantity (2021-2032) & (K Units)
Figure 17. Global Biologic Medications for Psoriasis Price (2021-2032) & (US$/Unit)
Figure 18. Global Biologic Medications for Psoriasis Sales Quantity Market Share by Manufacturer in 2025
Figure 19. Global Biologic Medications for Psoriasis Revenue Market Share by Manufacturer in 2025
Figure 20. Producer Shipments of Biologic Medications for Psoriasis by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 21. Top 3 Biologic Medications for Psoriasis Manufacturer (Revenue) Market Share in 2025
Figure 22. Top 6 Biologic Medications for Psoriasis Manufacturer (Revenue) Market Share in 2025
Figure 23. Global Biologic Medications for Psoriasis Sales Quantity Market Share by Region (2021-2032)
Figure 24. Global Biologic Medications for Psoriasis Consumption Value Market Share by Region (2021-2032)
Figure 25. North America Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 26. Europe Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 27. Asia-Pacific Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 28. South America Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 29. Middle East & Africa Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 30. Global Biologic Medications for Psoriasis Sales Quantity Market Share by Type (2021-2032)
Figure 31. Global Biologic Medications for Psoriasis Consumption Value Market Share by Type (2021-2032)
Figure 32. Global Biologic Medications for Psoriasis Average Price by Type (2021-2032) & (US$/Unit)
Figure 33. Global Biologic Medications for Psoriasis Sales Quantity Market Share by Application (2021-2032)
Figure 34. Global Biologic Medications for Psoriasis Revenue Market Share by Application (2021-2032)
Figure 35. Global Biologic Medications for Psoriasis Average Price by Application (2021-2032) & (US$/Unit)
Figure 36. North America Biologic Medications for Psoriasis Sales Quantity Market Share by Type (2021-2032)
Figure 37. North America Biologic Medications for Psoriasis Sales Quantity Market Share by Application (2021-2032)
Figure 38. North America Biologic Medications for Psoriasis Sales Quantity Market Share by Country (2021-2032)
Figure 39. North America Biologic Medications for Psoriasis Consumption Value Market Share by Country (2021-2032)
Figure 40. United States Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 41. Canada Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 42. Mexico Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 43. Europe Biologic Medications for Psoriasis Sales Quantity Market Share by Type (2021-2032)
Figure 44. Europe Biologic Medications for Psoriasis Sales Quantity Market Share by Application (2021-2032)
Figure 45. Europe Biologic Medications for Psoriasis Sales Quantity Market Share by Country (2021-2032)
Figure 46. Europe Biologic Medications for Psoriasis Consumption Value Market Share by Country (2021-2032)
Figure 47. Germany Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 48. France Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 49. United Kingdom Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 50. Russia Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 51. Italy Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 52. Asia-Pacific Biologic Medications for Psoriasis Sales Quantity Market Share by Type (2021-2032)
Figure 53. Asia-Pacific Biologic Medications for Psoriasis Sales Quantity Market Share by Application (2021-2032)
Figure 54. Asia-Pacific Biologic Medications for Psoriasis Sales Quantity Market Share by Region (2021-2032)
Figure 55. Asia-Pacific Biologic Medications for Psoriasis Consumption Value Market Share by Region (2021-2032)
Figure 56. China Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 57. Japan Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 58. South Korea Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 59. India Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 60. Southeast Asia Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 61. Australia Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 62. South America Biologic Medications for Psoriasis Sales Quantity Market Share by Type (2021-2032)
Figure 63. South America Biologic Medications for Psoriasis Sales Quantity Market Share by Application (2021-2032)
Figure 64. South America Biologic Medications for Psoriasis Sales Quantity Market Share by Country (2021-2032)
Figure 65. South America Biologic Medications for Psoriasis Consumption Value Market Share by Country (2021-2032)
Figure 66. Brazil Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 67. Argentina Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 68. Middle East & Africa Biologic Medications for Psoriasis Sales Quantity Market Share by Type (2021-2032)
Figure 69. Middle East & Africa Biologic Medications for Psoriasis Sales Quantity Market Share by Application (2021-2032)
Figure 70. Middle East & Africa Biologic Medications for Psoriasis Sales Quantity Market Share by Country (2021-2032)
Figure 71. Middle East & Africa Biologic Medications for Psoriasis Consumption Value Market Share by Country (2021-2032)
Figure 72. Turkey Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 73. Egypt Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 74. Saudi Arabia Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 75. South Africa Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 76. Biologic Medications for Psoriasis Market Drivers
Figure 77. Biologic Medications for Psoriasis Market Restraints
Figure 78. Biologic Medications for Psoriasis Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Biologic Medications for Psoriasis in 2025
Figure 81. Manufacturing Process Analysis of Biologic Medications for Psoriasis
Figure 82. Biologic Medications for Psoriasis Industrial Chain
Figure 83. Sales Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
Figure 1. Biologic Medications for Psoriasis Picture
Figure 2. Global Biologic Medications for Psoriasis Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Biologic Medications for Psoriasis Revenue Market Share by Type in 2025
Figure 4. TNF-α Inhibitors Examples
Figure 5. Interleukin Inhibitors Examples
Figure 6. Tyrosine Kinase Inhibitors Examples
Figure 7. Phosphodiesterase Inhibitors Examples
Figure 8. Other Examples
Figure 9. Global Biologic Medications for Psoriasis Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 10. Global Biologic Medications for Psoriasis Revenue Market Share by Application in 2025
Figure 11. Hospital and Clinic Examples
Figure 12. Retail Pharmacies Examples
Figure 13. Other Examples
Figure 14. Global Biologic Medications for Psoriasis Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 15. Global Biologic Medications for Psoriasis Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 16. Global Biologic Medications for Psoriasis Sales Quantity (2021-2032) & (K Units)
Figure 17. Global Biologic Medications for Psoriasis Price (2021-2032) & (US$/Unit)
Figure 18. Global Biologic Medications for Psoriasis Sales Quantity Market Share by Manufacturer in 2025
Figure 19. Global Biologic Medications for Psoriasis Revenue Market Share by Manufacturer in 2025
Figure 20. Producer Shipments of Biologic Medications for Psoriasis by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 21. Top 3 Biologic Medications for Psoriasis Manufacturer (Revenue) Market Share in 2025
Figure 22. Top 6 Biologic Medications for Psoriasis Manufacturer (Revenue) Market Share in 2025
Figure 23. Global Biologic Medications for Psoriasis Sales Quantity Market Share by Region (2021-2032)
Figure 24. Global Biologic Medications for Psoriasis Consumption Value Market Share by Region (2021-2032)
Figure 25. North America Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 26. Europe Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 27. Asia-Pacific Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 28. South America Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 29. Middle East & Africa Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 30. Global Biologic Medications for Psoriasis Sales Quantity Market Share by Type (2021-2032)
Figure 31. Global Biologic Medications for Psoriasis Consumption Value Market Share by Type (2021-2032)
Figure 32. Global Biologic Medications for Psoriasis Average Price by Type (2021-2032) & (US$/Unit)
Figure 33. Global Biologic Medications for Psoriasis Sales Quantity Market Share by Application (2021-2032)
Figure 34. Global Biologic Medications for Psoriasis Revenue Market Share by Application (2021-2032)
Figure 35. Global Biologic Medications for Psoriasis Average Price by Application (2021-2032) & (US$/Unit)
Figure 36. North America Biologic Medications for Psoriasis Sales Quantity Market Share by Type (2021-2032)
Figure 37. North America Biologic Medications for Psoriasis Sales Quantity Market Share by Application (2021-2032)
Figure 38. North America Biologic Medications for Psoriasis Sales Quantity Market Share by Country (2021-2032)
Figure 39. North America Biologic Medications for Psoriasis Consumption Value Market Share by Country (2021-2032)
Figure 40. United States Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 41. Canada Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 42. Mexico Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 43. Europe Biologic Medications for Psoriasis Sales Quantity Market Share by Type (2021-2032)
Figure 44. Europe Biologic Medications for Psoriasis Sales Quantity Market Share by Application (2021-2032)
Figure 45. Europe Biologic Medications for Psoriasis Sales Quantity Market Share by Country (2021-2032)
Figure 46. Europe Biologic Medications for Psoriasis Consumption Value Market Share by Country (2021-2032)
Figure 47. Germany Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 48. France Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 49. United Kingdom Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 50. Russia Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 51. Italy Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 52. Asia-Pacific Biologic Medications for Psoriasis Sales Quantity Market Share by Type (2021-2032)
Figure 53. Asia-Pacific Biologic Medications for Psoriasis Sales Quantity Market Share by Application (2021-2032)
Figure 54. Asia-Pacific Biologic Medications for Psoriasis Sales Quantity Market Share by Region (2021-2032)
Figure 55. Asia-Pacific Biologic Medications for Psoriasis Consumption Value Market Share by Region (2021-2032)
Figure 56. China Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 57. Japan Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 58. South Korea Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 59. India Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 60. Southeast Asia Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 61. Australia Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 62. South America Biologic Medications for Psoriasis Sales Quantity Market Share by Type (2021-2032)
Figure 63. South America Biologic Medications for Psoriasis Sales Quantity Market Share by Application (2021-2032)
Figure 64. South America Biologic Medications for Psoriasis Sales Quantity Market Share by Country (2021-2032)
Figure 65. South America Biologic Medications for Psoriasis Consumption Value Market Share by Country (2021-2032)
Figure 66. Brazil Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 67. Argentina Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 68. Middle East & Africa Biologic Medications for Psoriasis Sales Quantity Market Share by Type (2021-2032)
Figure 69. Middle East & Africa Biologic Medications for Psoriasis Sales Quantity Market Share by Application (2021-2032)
Figure 70. Middle East & Africa Biologic Medications for Psoriasis Sales Quantity Market Share by Country (2021-2032)
Figure 71. Middle East & Africa Biologic Medications for Psoriasis Consumption Value Market Share by Country (2021-2032)
Figure 72. Turkey Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 73. Egypt Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 74. Saudi Arabia Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 75. South Africa Biologic Medications for Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 76. Biologic Medications for Psoriasis Market Drivers
Figure 77. Biologic Medications for Psoriasis Market Restraints
Figure 78. Biologic Medications for Psoriasis Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Biologic Medications for Psoriasis in 2025
Figure 81. Manufacturing Process Analysis of Biologic Medications for Psoriasis
Figure 82. Biologic Medications for Psoriasis Industrial Chain
Figure 83. Sales Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source